FORM 8-K
SECURITIES and EXCHANGE COMMISSION
Washington D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or l5 (d) of
The Securities Exchange Act of 1934
MEDISCIENCE TECHNOLOGY CORPORATION
(exact name of registrant as specified in charter)
New Jersey 0-7405 22-1937826
(state of Incorporation) (commission file No.) (IRS Employer Identification No.)
1235 Folksone Way, Cherry Hill, New Jersey 08034
(address of principle executive offices)
Registrant's telephone number, including area code (856) 428 7952
--------------------------------------------------------------------------------
(former address, if changed since last report)
<PAGE>
Item 5. Other Materially Important Events
On August 14, 2000 Mediscience Technology Corp. and Sarnoff Research
Corp. (Princeton NJ) entered a letter of understanding establishing Sarnoff's
equity participation in a Joint Venture Company based on agreed to initial
capitalization and valuation. The party's purpose is to join respective
world-class Intellectual Property, Sarnoff engineering expertise and know-how to
develop Mediscience/Sarnoff optical diagnostic products as a broad platform of
commercial applications. (copy of 8/14/2000 letter of understanding attached and
made a part herof marked Exhibit A)
<PAGE>
SIGNATURES
Pursuant of the requirements of the Securities Exchange Act of 1934, In
Registrant has duly caused this report to be signed on its behalf by the
undesigned hereunto duly authorized
MEDISCIENCE TECHNOLOGY CORPORATION
/s/ Peter Katevatis
-----------------------------------
Peter Katevatis, Esq., Chairman
Dated April 20, 2000
